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Methods: A 31-year-old woman with a medical history o[ type I diabetes. 
hypothyroidism. proiactine aCeDoma, w;teopor().';i~ and nephrilic ~)'lldrOI1)C 
(all diseases were stable), was hospilalizcd for generalised maculopapular 
rash. fever. bilateral lymphadenopathies on cervical chain. Symptoms 
appeared 3 weeks after the initial of slllfasalazine treatment for chronic 
diarrhea. Initial laboratory tests were as fo'JIows: hypcrJeucocytosis 
(24 x IOJ/~), hypereosinophilia (5%, 1200) increase rransaminases 
(ASTI68 UIL, ALT 130 UIL), total bilirubin 28 mg/dl (NR 0.2-1), 
alkaline phosphatase (ALP) 269 U/L . rR < 140), gamma GT (186 Df 
L < 50). All test results for viral and autoimmune ilcpatitis were negative. 
DRESS syndrome to sulfasalazine ....'3., su.spectc:d. The patient was treated 
with corticosteroid. All symptoms improved aI'ter discontinuation of sul­
fa.·'.alazine aDd 4 weeks of corticosteroid Slcin bi<>psy showed a spongiotic 
epidermatitis with a many lymphocytic infiltrate and many necrotic ker­
atinocytes. In the dermis, biopsy showed important exu-avasation of red 
blood cells with inflammatory eosinophilic infiltrate suggestive of 
immunoallergic purpuric capillaritis. The diagnosis of DRESS syndrome 
to sulfasalazine was retained. The pach test was negative. 
Result~: Sulfasalazine is a compound consisting of sulphapyridine (a 
sulphonamide) and 5-aminosalicylic acid. Sulfasalazine is known to 
induce DRESS syndrome [2]. DRESS syndrome is a hypersensiriviry 
syndrome. It presents with severe cutaneous eruption, feva, lym­
phadenopathy, hepatitis. haematological abnormalities with eosinophilia, 
atypical lymphocytes and may also involve other organs. The multi-organ 
involvement differentiates thi s entity from other common drug erup!i () Il .. 
DRESS ha~ been associared with higher morbidity and mortalily compau 
to other adverse drug reactions [I J. 
Conclusion: Sulfasalazine is known to induce DRESS syndrome. Early 
diagnosis and treatment can reduced morbidity and mortality. 
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Backgroulldi/ntroducrion: 771e elderly cOl1slirute a parlicularly 
helerogeneous populalion, due /0 Ihe considerable variability 
associaled wilh Ihe aging process 
The characteristics of geriarric parients suggest that a large number of 
adverse events should occur in this population. 
Objecti\'elAim: The purpose of our study is 10 enumerate the adverse 
events occurring in patients over 65 years old and to classify them 
according to NCC MERP Index for Categorizing Medication Errors. This 
work also aims 10 list tile therapeutic classes involved in the occurrence of 
these adverse effects. 
Methods: This is a retrospective stUdy , from January 2010 to September 
2016. The method used to collect the adverse effects wa' spomaneous 
notitications. These cbLa are SUbsequently entered on the database of [he 

Moroccan Poison Comrol ud Plwmaco ·jgilaru:e Cenler. 

Results: On a 10lal of 16~~2~ cao;;e;; reported between 2010 and 2016. 990 

notifications correspond \0 adverse events observed in geriatric~, that is 

represented 6%. TIle mc:dim ~g b 72 }'ears. 

A tutal of 1491 side effects wen: reported, because each noti.ficalioll con­

tains one or Il1Qre :w~ene t:\·erus. 15% (n = 743) of tbe srudy population 

have mulridrugs. , 'atL'iC3 and vomiting,qualified category A, were the most 

obsen'ed with _R '£ (n = 106) foliowed by skin rash. category C, rep­

resenting 19. 1% (II = 189), and mi rd, general diwrders with 15.5% 

(n = 155); who iTCd hospilalizaJioo ~ qualified = egory F. 

The main therapeutic ctasseS are anticancer drugs with 26.1 % 

(11 =25S),lmowing thru Ibt tbt.~ dose was respcclCd, followed by 

cardiovascular system drug~ with n.R4 (n = 236) repr 'sented mainly by 

anrithrombotic agents and antihypertensives drugs with 22% (n = 218). 

Of the total cases, 26.5% (n =303) were cOIL,iliered sc\'ere, of which 59 

cases had cvolved towards death . 

Conclusion: The heterogeneity of the elderly population resulting i~ 

particular from a polymedicnrion and a large polYITlOlbidity is responsible 

for a very variable ther.IJ?Culic respmL~ according to the individuals, 

leading to therapeutic failures or to the occurrence of adverse events. 

With effective pharmacovigilaoc.e based on sponl3noous nolilication. 

however, it will be possible to sensiti7..e doctors to problematic drug 
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BackgroundlIntroductioo: In developed countrie.\ chronic disease is 
currently the main reason why people betake to health care [II. Negative 
effects of lion tlmpllance with m<:~caJ prescription reduce the clinical 
benefits of the medication, leading in most cases to the use of unnecessary 
trcatments, hospitalization and death 121. Factors as;;ociatcd with non­
compliance with medical prescription JIlay be related to: the doctor·patient 
reiatiollship, the treatment, the health system, the health condition and the 
socioeconomic situation. 
ObjectiveiAim: To assess the impact of the doctor-patient relationship on 
non-compliance with pharmacological medical prescription in chronic 
disease. 
Methods: A cross-sectional design was de\'eloped based on a random 
sample of 141 patients with pathologies covered by Portuguese Excep­
tional Legislalion. To collect the dam, it was applied a questionnaire by 
interview between July 2017 and April 201 S. The questionnaire induded a 
list of non-rompliance fac tors associated tQ doctor-patient relalion., hip, 
developed by Cabral & Silva (2010) P l. The ffiM SPSS 24.0 software wa' 
used to analyse the data. Besides descriptive statistics, the data analysis 
L\ Adis 
AbsO'acts 	 1205 
involved the estimation of a logistic regression model. at a confidence 
level of 95%. 
Results: Chronic patients were aged between 20 and 95 years old. with a 
mean age of 65.3 years (SD = 19.39). Most were female (51.8%). married 
or lived in marital cohabitation (62.4%). retired (55.3%). and had up to the 
3rd cycle of schooling (61 %) and an income up to € 1000 (62.4%). These 
patients suffered from Chronic Renal Insufficiency (CRI) (63 .1 %). 
Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PA) (20.6%). Multiple 
Sclerosis (lI.-IS) (10.6%). Amyotrophic Lateral Sclerosis (ALS) (2.1%). 
Hepatitis C Virus (HCV) (21 %), Hepatic disease (HD) (0.7%) and Gau­
cher Syndrome (GS) (0.7%). The aclive substances most dispensed were: 
ferrous sulphate (76.6%), folic acid (73.ll%). calcium polysterenollosul­
fonate (53.2%), alfacalcidol (48.9%), epoelio jl (4J.3%). complex B 
(262%) for CRI; adalimumab (8.5%), etamecept (7.1 %) and Ustecinumab 
(4.3%) for RA and PA; inte"feron B (8.5%) for MS. Modal treatment time 
was 24 months. The main reason for non-compliance associated 10 doctor­
patient relationship dimension was "the tloctor prescribes too many 
medicines" (35%). The second most mentioned reason was "the fear to 
ask questions" (18.4%), followed by "I do not understand what doctors 
say" (17.5%) and the "lack of confidence in docrers" (6.R%). A patient 
who does not consider thar " the doctor prescribes 100 many medications" 
has a lower risk of non-compliance with the therapeutic prescription 
[OR = 0.262; cr (95%) 0.1 12--0.617). 
Conclusion: The doctor-patient relationship is fundamental for compli­
ance with the presc ,;bed therapy and consequently for the improvement of 
the clinical benefits of medication and well-being of the patient. 
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BackgronndlIotroduction: Isotretinoin. a retinoid derivative of Vitamin 
A. is an oral medicine first approvedin the US in 19R2 that is prescribed 
for the treatment of acne when other treatments do not work. Within a few 
years after launch. it became apparent that exposure to isotretinoin tluring 
pregnancy carried a greatly increa,;ed risk of foeral malformation. 
Numerous s!antlartl risk management approaches basetl on labelling anti 
education have failed to adequately prevent women becoming pregnant 
whilst using this medicine. Several strategies, basetl on pregnancy pre­
vention programmes (PPPs), have helped reduce the number of 
pregnancies in women recei ving retinoids by mouth, but the number of 
pregnancies remains unacceptably high. Indeed, a recent analysis of the 
effectiveness of PPPs suppmtedthe widespread suspicion that they are not 
being followed in practice and that there is enormou.< inconsistency 
globally. Because isotretinoin is a valuable medicine for disfigwing acne, 
there is a need to intens ify efforts to control pregnancy in exposed women 
an ti develop a common model which can be understootl anti applied 
internationally. 
ObjectivelAim: The aim of this original research Wa!; to apply Causal 
An~lysis using System Theory (CAST) based on Systems Theoretic 
Accident Model and Processes (STAMP) 110 analyze the spontaneous 
events of pregnancies that have reported during Of after the administration 
of isotretinoin in Ihe UK and 10 idrolify vulnerabilities and fl aws io the 
safety management system. 
Methods: The po.st-allihorizaIioa SfI'OIII.iIne()U;' ClSe$ "'ere oOOlincd from 
the EudraVigilancc databiL<e of lIle European Medicines Agency (EMA) 
via the Medicines and Heal thcare Products Regulatory Agency (MHRA). 
The data concerned cases o f pregnancies that had been reported to the 
MHRA in the United Kingdom during the period 01 January 2005 to 30 
September 2017. 
Results: TI,e results included imponant failures of the controllers and of 
rhe physical component of rhe system , revealing failures in rwo control 
loops in the safery control stmcmre of the system. Based on the unsafe 
control actions that were revealed, we have advised some changes in the 
Pregnancy Prevention Program with several recommendations fur the 
controllers of the system. 
Conclusion: CAST revealed important failures and system complacency 
across the different levels. Furthermore the ='y application of CAST 
might well be an important way for investigating systems future failures 
concerning teratogenic drugs and pregnancy cases. CAST showed that 
such spontaneous reports of pregnancy can contribnre real value in causal 
analysis when the information is pooled systematically. 
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BackgroundJlntrodoction: Medication adherence is a multidimensional 
phenomenon determined by the interaction of facrors of diverse nature. 
The World Health Organization classified in tive groups the reasons for 
non-adherence to therapy. related ro. patient. disease, therapy. health 
system and socioeconomic factors [I]. 
Objective/Aim: To identify the most prevalent extrinsic and intrinsic 
factors for non-adherence to therapy and to verify the existing differences 
raking into accollnt the socioeconomic variables. 
Methods: A random probabili stic sample of 14 I outpatient suffering from 
pathologie.< covered by specific legislation with dispensing medicines at 
the hospital pharmacy. trented at the Local Health Unir of the Nonheast in 
!...\ Adis 
